2012 Dodge Avenger R/T
3.6 L • 6 • 283 hp • FWD • AT
1C3CDZBG1CN182657
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
3.6 L • 6 • 283 hp • FWD • AT
Odometer
184,876 mi ≈ 297,528 km
Primary damage
Front end
Docs
MN • Salvage
Extra
Auction
VIN
1C3CDZBG1CN182657
Lot number
80027614
Copart
Sale status
Sold
Seller type
Insurance
Seller
GEICO
Location
Minneapolis North, MN
Description
Fuel type
Gasoline
Body color
Orange
Body type
Sedan
Generation
JS
Trim
R/T
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Dodge models
2012 Dodge Avenger R/T • 3.6 L • 6 cyl • 283 hp • FWD • Automatic • Copart Lot: 80027614 • VIN: 1C3CDZBG1CN182657
Find out more about this 2012 Dodge Avenger R/T, available at the Copart salvage car auction as lot 80027614 in Minneapolis North, MN. This car has Front end main damage. It is listed with Run and drive start condition code. Odometer shows 184,876 mi. This Orange Dodge Avenger Sedan is equipped with Gasoline 3.6 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 1C3CDZBG1CN182657 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
